Advance Agrolife Ltd(ADVANCE)

NSE: ADVANCEBSE: 544562

₹ 135.05-5.95%refreshed 23 Oct, 03:30 pm ISTMarket cap: ₹ 868 crWebsite: www.advanceagrolife.comUpdated: 24 Oct 2026

About

Advance Agrolife makes technical and formulated agrochemicals, including insecticides, fungicides, herbicides and plant growth regulators, and works mainly as a B2B partner to leading agrochemical companies. It has 89,900 MTPA of installed capacity across three plants in Jaipur, Rajasthan, and its Unit II is described as among the largest sulphur formulation setups globally. FY26 revenue was Rs 637.77 Cr.^[1][2]

Business segments

Formulation grade products made up 92.34% of revenue in FY26, technical grade 6.26% and others 1.40%.^[1]
By product type in FY26, herbicides were 40.83% of revenue, fungicides 26.40% and insecticides 24.56%.^[1]

Products and registrations

The portfolio had over 410 product registrations as of FY26, and 410+ CIB & RC registrations in Q1 FY27.^[1][3]
The company is moving its mix away from commodity bulk chemicals toward specialised WDG and SC formulations made at Unit II (stated in Q4 FY26 and Q1 FY27).^[3][4]
A new R&D laboratory was set up to develop new product combinations (Q3 FY26).^[5]

Manufacturing plants and capacity

Installed capacity was 89,900 MTPA across three plants in Jaipur, Rajasthan, as of FY26 and Q1 FY27.^[1][3]
Unit I at Bagru, Jaipur, is the technical manufacturing hub with 6,900 MT capacity (FY26). It was converted from formulation to herbicide, insecticide and fungicide technicals and now supplies the formulation units.^[1][3]
Unit II at Dahami Khurd, Jaipur, is a dedicated sulphur-based formulation plant with 51,000 MT capacity (FY26).^[1]
Unit III at Dhami Khurd, Jaipur, is a high-volume formulation plant with 32,000 MT capacity (FY26).^[1]
Production of Pretilachlor Technical (5,000 MT p.a.) and its intermediate PEDA (3,700 MT p.a.) began at Bagru in Q4 FY26. Pretilachlor runs at 13 TPD and production had stabilised by Q1 FY27.^[4][3]
A 3.75 MW solar power plant is being set up (Q4 FY26).^[4]

Customers and markets

The top 10 customers contributed ~69% of revenue (Q4 FY26). Named clients include DCM Shriram, IFFCO, Mankind Agritech, Chambal Fertilisers, NFL and Zuari.^[4]
94 customers had been with the company for more than three years (FY26).^[1]
The company is present in 19 states in India and 7 countries (FY26).^[1]
Domestic sales were 97.7% of revenue and foreign sales 2.3% in FY26. The company targets a 20% export share by FY29, with a focus on LATAM, SE Asia and Brazil.^[1][3]
The company is seeking product registrations in international markets, including Europe (FY26).^[1]

Expansion projects

The Unit IV technical plant at Gidani is now due to start by Q3 FY27, later than the earlier Q2 FY27 target. Phase 1 capex is ~₹250 million, and the company targets a 25-30% COGS reduction on specific products.^[3][4]
Construction of Unit V for technical grade pesticides began at Dahej II GIDC, Bharuch, Gujarat, on 17,734.54 sq. mtrs of land (Q1 FY27). A land MOU had been signed in Q4 FY26.^[3][4]
The company plans to expand 2,4-D herbicide capacity 4x to 10,000 MT, with a Q4 FY28 target.^[3]

Recent developments

Q1 FY27 revenue from operations was ₹3,304 mn, up 96% YoY. Management credited inventory funded by working capital from the IPO proceeds.^[3]
In Q4 FY26, CARE upgraded the rating on ₹1,008.9 million of long-term bank facilities from BBB to BBB+.^[4]
The company has no subsidiaries, associates or joint ventures (FY26).^[1]

Market Cap

₹868 Cr

High / Low

₹165 / 85

Stock P/E

20.8

Price / Book

3.3

Book Value

₹48

EPS

₹5.5

No. of Shares

6.43 Cr

ROCE

14.0%

ROE

11.4%

OPM

8.8%

Debt / Equity

0.31

Sales

₹638 Cr

Net Profit

₹35 Cr

Promoter holding

69.9%

Loading chart…

Signal history

AI Deep Dive

The analysis Screener can't give you

Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:

Verdict
The headline call - descriptive label, conviction, and the synthesis behind it.
Valuation
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Walk the talk
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Red flags
Forensic and governance risk pointers, severity-ranked.
Balance sheet
Solvency and earnings-quality score.
Concall briefs
Quarter-by-quarter earnings-call briefs - what changed and why.

₹49 unlocks this company for 90 days, ₹299 for a full year - bundles bring it lower. Built on public disclosures - educational, not investment advice.

AI Deep Dive

Verdict

Locked

The headline call - descriptive label, conviction, and the synthesis behind it.

Company data

Financials